Zhejiang Huaye Plastics Machinery
301616
Alnera Aluminium
301613
Glory View Technology
301396
4
Guangzhou Sie Consulting
300687
5
Tibet Duo Rui Pharmaceutical
301075
CN Stock MarketDetailed Quotes
601188 Heilongjiang Transport Development
- 3.28
- -0.02-0.61%
Market Closed Mar 31 15:00 CST
4.32BMarket Cap28.28P/E (TTM)
3.38High3.26Low226.13KlotVolume3.33Open3.30Pre Close74.70MTurnover1.72%Turnover Ratio28.28P/E (Static)1.32BShares4.3552wk High0.94P/B4.32BFloat Cap2.8852wk Low3.63Limit Up1.32BShs Float9.20Historical High2.97Limit Down3.64%Amplitude1.29Historical Low0.06Dividend TTM3.30Avg Price119.60KlotAsk1.95%Div YieldTTM100Lot Size101.67KlotBid
Heilongjiang Transport Development Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 28.03%847.37M | -11.40%427.19M | -19.70%228.03M | -11.56%112.32M | 52.05%661.85M | 38.95%482.15M | 46.38%283.96M | 49.53%127M | -18.90%435.27M | -18.73%347.01M |
| Operating revenue | 28.03%847.37M | -11.40%427.19M | -19.70%228.03M | -11.56%112.32M | 52.05%661.85M | 38.95%482.15M | 46.38%283.96M | 49.53%127M | -18.90%435.27M | -18.73%347.01M |
| Other operating revenue | 36.35%1.44M | ---- | -64.97%137.74K | ---- | -73.81%1.06M | ---- | -29.63%393.19K | ---- | 42.82%4.04M | ---- |
| Total operating cost | 35.70%728.36M | -3.10%303.72M | -2.26%171.5M | 9.30%81.44M | 56.90%536.76M | 38.42%313.44M | 45.51%175.46M | 64.67%74.51M | -11.70%342.1M | -11.74%226.45M |
| Operating cost | 40.85%620.26M | -9.44%231.85M | -13.66%124.29M | -0.55%59.37M | 42.99%440.37M | 33.61%256.03M | 42.51%143.96M | 65.04%59.7M | -4.86%307.97M | -14.77%191.62M |
| Operating tax surcharges | 425.04%8.15M | 304.56%6.88M | 148.30%2.99M | 66.64%2.2M | 89.06%-2.51M | -214.86%-3.36M | -415.98%-6.19M | 45.15%1.32M | -382.32%-22.92M | -55.36%2.93M |
| Operating expense | -42.86%3.8M | -44.22%2.4M | -52.59%1.56M | -28.63%881.13K | 23.30%6.65M | 5.36%4.31M | 79.32%3.28M | 3.04%1.23M | -20.45%5.39M | 11.93%4.09M |
| Administration expense | 4.54%104.17M | 9.12%67.33M | 21.22%46.16M | 52.67%21.71M | 53.00%99.64M | 59.46%61.7M | 60.62%38.08M | 24.72%14.22M | 13.39%65.12M | -6.11%38.69M |
| Financial expense | 11.59%-9.38M | 10.39%-6.85M | 6.40%-4.53M | -23.18%-2.72M | 21.17%-10.61M | 29.74%-7.64M | 39.04%-4.84M | 50.16%-2.21M | -56.35%-13.46M | 44.69%-10.88M |
| -Interest expense (Financial expense) | 411.01%997.99K | --424.56K | --344.04K | --30.34K | -17.14%195.3K | ---- | ---- | ---- | 10.46%235.69K | --113.8K |
| -Interest Income (Financial expense) | 4.64%-10.49M | 9.75%-6.92M | -1.72%-4.96M | -24.32%-2.77M | 20.24%-11.01M | 30.83%-7.67M | 39.62%-4.88M | 50.91%-2.23M | -55.13%-13.8M | ---11.09M |
| Research and development | -57.68%1.36M | -12.74%2.11M | -12.97%1.02M | ---- | --3.22M | --2.42M | --1.17M | --241.33K | ---- | ---- |
| Credit Impairment Loss | -114.10%-118.65K | -45.16%491.71K | 254.86%303.42K | --107.11K | 149.34%841.56K | -77.20%896.55K | --85.5K | ---- | -51.53%337.52K | 1,782.10%3.93M |
| Asset Impairment Loss | 88.96%-2.37M | ---- | ---- | ---- | ---21.47M | ---- | ---- | ---- | ---- | ---- |
| Other net revenue | 33.22%58.04M | 16.71%60.6M | -0.17%34.4M | 49.81%29.01M | -44.59%43.56M | -29.61%51.93M | -28.31%34.46M | -34.01%19.37M | -12.60%78.62M | 29.31%73.77M |
| Fair value change income | -11.35%-8.46M | 41.60%-5.44M | -6.28%-7.74M | 50.42%-3.18M | -64.05%-7.6M | -172.25%-9.32M | -418.30%-7.29M | -377.39%-6.41M | 74.55%-4.63M | 84.37%-3.42M |
| Invest income | -3.27%66.95M | 11.01%64.77M | -0.00%41.12M | 25.60%31.91M | -14.73%69.21M | -19.00%58.34M | -8.41%41.12M | -16.96%25.4M | -24.38%81.17M | -7.97%72.03M |
| -Including: Investment income associates | 36.99%53.84M | 45.25%50.41M | 18.34%30.53M | 58.67%25.93M | -15.54%39.3M | -27.14%34.71M | -20.06%25.8M | -33.36%16.34M | -20.07%46.53M | -14.15%47.63M |
| Asset deal income | 988.44%1.36M | 112.96%210.71K | 234.53%267.02K | -34.38%39.54K | 124.45%125.04K | 126.87%98.95K | -179.76%-198.49K | 177.27%60.25K | 9.43%-511.35K | -1,384.96%-368.3K |
| Other revenue | -72.20%683.74K | -69.70%578.01K | -38.23%456.19K | -56.32%134.95K | 8.77%2.46M | 19.48%1.91M | -22.60%738.57K | 74.68%308.98K | 221.77%2.26M | 205.97%1.6M |
| Operating profit | 4.97%177.05M | -16.57%184.07M | -36.39%90.94M | -16.66%59.89M | -1.82%168.66M | 13.54%220.64M | 17.69%142.96M | 4.09%71.86M | -28.20%171.79M | -14.56%194.33M |
| Add:Non operating Income | 1,020.31%4.7M | 13.67%428.66K | -1.26%290.15K | 14.38%51.89K | -62.98%419.7K | -43.30%377.1K | -1.53%293.84K | -83.31%45.37K | 6.87%1.13M | -12.61%665.1K |
| Less:Non operating expense | -48.02%827.25K | 27.87%945.33K | 11.70%634.45K | 3,254.08%594.53K | 11.88%1.59M | 312.59%739.31K | 240.45%567.98K | --17.73K | -82.95%1.42M | -95.73%179.19K |
| Total profit | 8.02%180.92M | -16.67%183.55M | -36.51%90.6M | -17.45%59.35M | -2.34%167.49M | 13.07%220.27M | 17.33%142.69M | 3.72%71.89M | -26.07%171.5M | -13.04%194.81M |
| Less:Income tax cost | -21.59%26.99M | -17.47%32.61M | -32.24%13.72M | 1.09%7.39M | 9.41%34.43M | 29.70%39.51M | 8.73%20.25M | -28.26%7.31M | -41.82%31.47M | -29.36%30.46M |
| Net profit | 15.68%153.93M | -16.50%150.94M | -37.21%76.87M | -19.54%51.96M | -4.98%133.06M | 9.99%180.76M | 18.89%122.44M | 9.23%64.58M | -21.29%140.04M | -9.15%164.35M |
| Net profit from continuing operation | 15.68%153.93M | -16.50%150.94M | -37.21%76.87M | -19.54%51.96M | -4.98%133.06M | 9.99%180.76M | 18.89%122.44M | 9.23%64.58M | -21.29%140.04M | -9.15%164.35M |
| Less:Minority Profit | -69.42%1.53M | -70.05%1.81M | -94.58%426.13K | -42.90%1.02M | -70.58%5M | 49.47%6.04M | 293.92%7.87M | 957.78%1.79M | 72.85%16.99M | -48.75%4.04M |
| Net profit of parent company owners | 19.00%152.4M | -14.64%149.13M | -33.27%76.45M | -18.88%50.94M | 4.07%128.06M | 8.99%174.72M | 13.45%114.57M | 6.52%62.79M | -26.79%123.05M | -7.34%160.31M |
| Earning per share | ||||||||||
| Basic earning per share | 18.96%0.1167 | -18.12%0.113 | -33.33%0.058 | -18.75%0.039 | 4.14%0.0981 | 13.30%0.138 | 12.99%0.087 | 6.67%0.048 | -26.29%0.0942 | -7.02%0.1218 |
| Diluted earning per share | 18.96%0.1167 | -18.12%0.113 | -33.33%0.058 | -18.75%0.039 | 4.14%0.0981 | 13.30%0.138 | 12.99%0.087 | 6.67%0.048 | -26.29%0.0942 | -7.02%0.1218 |
| Other composite income | 34.54%17.81M | 328.65%13.24M | -148.56%-5.79M | |||||||
| Other composite income of parent company owners | 34.54%17.81M | ---- | ---- | ---- | 328.65%13.24M | ---- | ---- | ---- | -148.56%-5.79M | ---- |
| Total composite income | 17.39%171.74M | -16.50%150.94M | -37.21%76.87M | -19.54%51.96M | 8.98%146.3M | 9.99%180.76M | 18.89%122.44M | 9.23%64.58M | -29.28%134.25M | -9.15%164.35M |
| Total composite income of parent company owners | 20.46%170.21M | -13.74%149.13M | -33.27%76.45M | -18.88%50.94M | 20.50%141.3M | 7.85%172.9M | 13.45%114.57M | 6.52%62.79M | -34.86%117.26M | -7.34%160.31M |
| Total composite income of minority owners | -69.42%1.53M | -77.01%1.81M | -94.58%426.13K | -42.90%1.02M | -70.58%5M | 94.68%7.87M | 293.92%7.87M | 957.78%1.79M | 72.85%16.99M | -48.75%4.04M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | ZTE Caiguanghua Certified Public Accountants Co., Ltd. (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.